[Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results BEIJING, Nov. 2, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter, ended September 30, 2015, after the market closes on Wednesday, November 11, 2015. The] [Sinovac to Participate in Morgan Stanley Asia Pacific Summit th BEIJING, November 4, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the 14 About Sinovac www.sinovac.com Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines] []

[Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate BEIJING, Oct. 26, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted] []

[Sinovac to Participate in Morgan Stanley Global Healthcare Conference BEIJING, September 10, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate the Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt Hotel in New York City from Wednesday September 16 to Friday September 18,] [Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing BEIJING, September 14, 2015 -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the Beijing government to be a supplier of the seasonal influenza vaccine for its 2015 vaccination campaign. The Beijing government plans to order a] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v420222_6k.htm FORM 6-K]

[Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results · · Pageview: 1308 BEIJING, August 4, 2015 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter, ended June 30, 2015, after market close on Wednesday, August 12,] [Sinovac Announces Results of 2015 Annual General Meeting of Shareholders · · Pageview: 447 BEIJING, August 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC. The required quorum, a majority of] [Sinovac Reports Unaudited Second Quarter Financial Results -- Conference call scheduled for Thursday, August 13, 2015 at 8:00 AM ET · · Pageview: 254 BEIJING, Aug.12, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015. Second] []

[Sinovac Reports Unaudited First Quarter 2015 Financial Results - Conference call scheduled for May 15, 2015 at 8:00 a.m. ET - BEIJING, May 14, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for the first quarter ended March 31, 2015. First Quarter 2015 Financial Highlights (Compared to] []